Stock Price & Analysis

Based on the latest data and significant news, here's a comprehensive analysis of RGA stock:

Breaking News Impact RGA has just announced a major reinsurance deal with Equitable Holdings:

• Reinsuring 75% of Equitable's life insurance liabilities ($32 billion total)
• $18 billion in general account reserves
• $14 billion in separate account reserves
• Expected to generate $70 million in adjusted operating income before taxes in 2025, increasing to $160-170 million in 2026

Market Response

• Current Trading: Up 6.61% at $201.895 during regular market hours
• Strong volume of 506,394 shares, indicating significant investor interest
• Pre-market showed positive momentum with +0.64%

Technical Analysis

• Stock is showing strong bullish momentum following the deal announcement
• Currently testing Fibonacci resistance level at R1: $217.52
• Support levels identified at S1: $190.94 and S2: $182.73

Fundamental Strength

• AM Best recently affirmed RGA's A+ (Superior) rating
• Strong balance sheet with very strong risk-adjusted capitalization
• Diversified global presence with approximately half of revenue from international operations
• Improving mortality experience since 2022

Buy/Sell Recommendation Based on the transformative deal announcement, strong technical momentum, and fundamental strength, RGA stock presents a compelling BUY opportunity at current levels. The stock has room to run toward the Fibonacci R1 level of $217.52, representing approximately 7.7% upside from current prices.

Based on the provided data and context, I'll analyze RGA's price prediction for 2025:

Technical Analysis

The stock is currently showing bearish signals with RSI at 27.18 (oversold territory) and MACD trending downward (-7.15) with a negative histogram (-2.77). The stock is trading below both its 20-day (214.10) and 60-day (216.74) moving averages, indicating a short-term downtrend.

Price Levels and Support/Resistance

Key Fibonacci levels for RGA:

• Resistance R3: $239.02
• Resistance R2: $225.73
• Resistance R1: $217.52
• Pivot: $204.23
• Support S1: $190.94
• Support S2: $182.73
• Support S3: $169.44

Fundamental Factors

• The company maintains a healthy dividend yield of 1.54%
• Recent analyst ratings show a generally positive outlook with 4 out of 5 analysts giving "Somewhat Bullish" ratings
• Average analyst price target is $245.60, with a range of $232-$255

2025 Price Prediction

Based on technical and fundamental analysis, here are the three scenarios for RGA stock price in 2025:

Base Case ($235-245): 60% probability

• Supported by analyst consensus price targets
• Assumes continued stable business performance
• Represents ~20% upside from current levels

Bull Case ($255-265): 25% probability

• Driven by strong execution and potential market share gains
• Aligned with most optimistic analyst targets
• Would require significant improvement in technical indicators

Bear Case ($190-200): 15% probability

• If market conditions deteriorate significantly
• Technical weakness persists
• Support levels break down

The most likely scenario is the base case, supported by:

1. Strong analyst consensus
2. Current oversold conditions suggesting potential rebound
3. Stable fundamental metrics

The S1 support level for RGA Stock is $191.59 ,The R1 resistant level for RGA Stock is $203.9.

As of the end of day on 2025-03-03, the price of RGA Stock was $201.98.

The target price for RGA Stock according to analyst rating is 250.11, with the highest price target at 280.00 and the lowest at 228.00. Analysts have a Moderate Buy rating on RGA Stock overall.

The market cap of RGA is $13.4B.

Based on the latest data and news, RGA appears fairly valued at current levels. The stock has surged 6.58% today to $201.85 following a major reinsurance deal with Equitable Holdings. The agreement to reinsure 75% of Equitable's life insurance liabilities ($32 billion) is expected to generate significant earnings growth, with adjusted operating income projected at $70 million in 2025 and $160-170 million in 2026. Technical indicators show RSI at 27.18 suggesting oversold conditions, while price is trading below key moving averages indicating some technical weakness. The stock's current price sits between Fibonacci support at $190.94 and resistance at $217.52. AM Best recently affirmed RGA's A+ (Superior) rating, citing its very strong balance sheet and favorable business profile. Analysts maintain a generally bullish stance with an average price target of $245.60, suggesting meaningful upside potential from current levels.

Reinsurance Group of America, Incorporated is an insurance holding company. The Company is a provider of traditional life and health reinsurance and financial solutions. The Company has four segments. The U.S. and Latin America Traditional segment provides individual and group life and health reinsurance, including long-term care, to domestic clients for a variety of products. The Canada Traditional segment is primarily engaged in individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. The Europe, Middle East and Africa Traditional segment provides individual and group life and health products through yearly renewable term and coinsurance agreements, reinsurance of critical illness coverage. The Asia Pacific Traditional segment provides individual and group life and health reinsurance, critical illness coverage, disability and superannuation through yearly renewable term and coinsurance agreements.

Based on the available data and market analysis, RGA stock is projected to reach approximately $285 by 2030, driven by its strong financial performance with $22.1 billion revenue and consistent dividend growth showing stable business fundamentals. The company's moderate P/E ratio of 19.93 and healthy net margin of 3.27% suggest sustainable growth potential, while its strategic position in the reinsurance industry provides defensive characteristics during market uncertainties.

RGA has a total of 3900 employees.